Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | LIN28A | Q9H9Z2 | 1/20 | 1.00 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | HRH1 | P35367 | 1/20 | 0.48 |
| ▸ | TERT | O14746 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29427509 | 1.00 | TDP1 (1.00) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 | |
| SCHEMBL10609540 | 0.98 | TDP1 (0.96) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 | |
| SCHEMBL6864020 | 0.92 | MAPT (0.85) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 | |
| SCHEMBL7107996 | 0.91 | MAPT (0.84) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 | |
| SCHEMBL138261 | 0.91 | SMN1; SMN2 (0.83) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 | |
| SCHEMBL6864949 | 0.90 | TDP1 (0.81) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 | |
| SCHEMBL343596 | 0.90 | SMN1; SMN2 (0.81) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 | |
| SCHEMBL5562538 | 0.90 | SMN1; SMN2 (0.81) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 | |
| SCHEMBL8772399 | 0.90 | TDP1 (0.81) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 | |
| SCHEMBL23642699 | 0.89 | TDP1 (0.79) | TDP1MAPTSMN1; SMN2LIN28AKCNA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2034 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4741492-A2 | NECROSIS INHIBITOR | Linkgevity Limited (GB) | 2026-05-13 | — | — | EP | claimed |
| US-12558409-B2 | Streptococcal vaccine formulations and uses thereof | GPN Vaccines Ltd (AU) | 2026-02-24 | — | — | US | claimed |
| US-20260028685-A1 | Saliva Stabilization Solution For Use In Nucleic Acid Amplification Reactions And Methods Of Use For The Detection Of Pathogen Nucleic Acids | UNIV COLORADO REGENTS (US) | 2026-01-29 | — | — | US | claimed |
| EP-4648769-A2 | NECROSIS INHIBITOR | Linkgevity Limited (GB) | 2025-11-19 | — | — | EP | claimed |
| US-12398389-B2 | Methods for isolating nucleic acids with size selection | NATERA, INC. (US) | 2025-08-26 | — | — | US | claimed |
| EP-4028494-B1 | REDUCING FRICTION IN COMBUSTION ENGINES THROUGH FUEL ADDITIVES | CHEVRON ORONITE CO (US) | 2025-08-06 | — | — | EP | claimed |
| CN-115857351-B | Solid oxide fuel cell system model and testing method | 华中科技大学 | 2025-05-30 | — | — | CN | claimed |
| US-20250161186-A1 | LIQUID BOTULINUM TOXIN FORMULATION AND USE THEREOF | MERZ PHARMA GMBH & CO. KGAA (DE) | 2025-05-22 | — | — | US | claimed |
| US-20250152682-A1 | LIQUID BOTULINUM TOXIN FORMULATION AND USE THEREOF | MERZ PHARMA GMBH & CO. KGAA (DE) | 2025-05-15 | — | — | US | claimed |
| EP-3042645-B2 | Dental composites with improved storage stability | IVOCLAR VIVADENT AG (LI) | 2025-03-12 | — | — | EP | claimed |
| US-20030203973-A1 | Preventing and/or treating cardiovascular disease and/or associated heart failure | PHILERA NEW ZEALAND LIMITED (NZ) | 2003-10-30 | — | — | US | claimed |
| WO-2003087079-A1 | CONVERSION OF TAXANE MOLECULES | NATURAL PHARMACEUTICALS, INC. (US) | 2003-10-23 | — | — | WO | claimed |
| EP-0740528-B1 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX THERAPEUTICS INC (US) | 2003-03-26 | — | — | EP | claimed |
| US-6231852-B1 | Method for reducing BCL-2 expressing cells resistance to death | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-05-15 | — | — | US | claimed |
| US-6022490-A | FOR ACTIVATING PEROXY BLEACH | LEVER BROTHERS COMPANY (US) | 2000-02-08 | — | — | US | claimed |
| EP-0740528-A4 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP (US) | 1998-04-01 | — | — | EP | claimed |
| US-5733572-A | Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles | IMARX PHARMACEUTICAL CORP. (US) | 1998-03-31 | — | — | US | claimed |
| WO-1997009976-A2 | METHOD OF REDUCING NEUROTOXIC INJURY WITH ZINC CHELATORS | WASHINGTON UNIVERSITY (CH) | 1997-03-20 | — | — | WO | claimed |
| EP-0740528-A1 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP. (US) | 1996-11-06 | — | — | EP | claimed |
| WO-1995015118-A1 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP. (US) | 1995-06-08 | — | — | WO | claimed |